Two Sigma Investments’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.14M | Buy |
475,612
+180,429
| +61% | +$721K | ﹤0.01% | 2706 |
|
|
2025
Q4 | $1.12M | Buy |
295,183
+160,454
| +119% | +$624K | ﹤0.01% | 2839 |
|
|
2025
Q3 | $435K | Sell |
134,729
-768,882
| -85% | -$2.88M | ﹤0.01% | 3047 |
|
|
2025
Q2 | $2.61M | Buy |
903,611
+508,866
| +129% | +$1.18M | ﹤0.01% | 1644 |
|
|
2025
Q1 | $849K | Buy |
394,745
+308,957
| +360% | +$977K | ﹤0.01% | 2267 |
|
|
2024
Q4 | $332K | Sell |
85,788
-33,719
| -28% | -$223K | ﹤0.01% | 2705 |
|
|
2024
Q3 | $783K | Sell |
119,507
-31,150
| -21% | -$250K | ﹤0.01% | 2254 |
|
|
2024
Q2 | $1.09M | Sell |
150,657
-59,815
| -28% | -$458K | ﹤0.01% | 1935 |
|
|
2024
Q1 | $1.6M | Buy |
210,472
+176,443
| +519% | +$1.37M | ﹤0.01% | 1642 |
|
|
2023
Q4 | $155K | Sell |
34,029
-27,887
| -45% | -$94.1K | ﹤0.01% | 2888 |
|
|
2023
Q3 | $245K | Sell |
61,916
-120,901
| -66% | -$457K | ﹤0.01% | 2570 |
|
|
2023
Q2 | $572K | Sell |
182,817
-30,178
| -14% | -$123K | ﹤0.01% | 2277 |
|
|
2023
Q1 | $965K | Buy |
212,995
+95,581
| +81% | +$499K | ﹤0.01% | 1883 |
|
|
2022
Q4 | $485K | Buy |
117,414
+41,472
| +55% | +$142K | ﹤0.01% | 2039 |
|
|
2022
Q3 | $243K | Buy |
75,942
+53,230
| +234% | +$133K | ﹤0.01% | 2037 |
|
|
2022
Q2 | $45K | Sell |
22,712
-5,700
| -20% | -$16.8K | ﹤0.01% | 2356 |
|
|
2022
Q1 | $115K | Buy |
28,412
+9,701
| +52% | +$63.5K | ﹤0.01% | 2417 |
|
|
2021
Q4 | $202K | Sell |
18,711
-11,896
| -39% | -$132K | ﹤0.01% | 3926 |
|
|
2021
Q3 | $353K | Buy |
+30,607
| New | +$367K | ﹤0.01% | 3536 |
|
|
2020
Q3 | – | Sell |
-14,149
| Closed | -$182K | – | 3354 |
|
|
2020
Q2 | $182K | Sell |
14,149
-4,465
| -24% | -$52K | ﹤0.01% | 2669 |
|
|
2020
Q1 | $172K | Sell |
18,614
-18,324
| -50% | -$241K | ﹤0.01% | 2704 |
|
|
2019
Q4 | $492K | Sell |
36,938
-1,759
| -5% | -$16.8K | ﹤0.01% | 2816 |
|
|
2019
Q3 | $343K | Buy |
38,697
+10,183
| +36% | +$112K | ﹤0.01% | 2859 |
|
|
2019
Q2 | $407K | Buy |
28,514
+11,010
| +63% | +$293K | ﹤0.01% | 2652 |
|
|
2019
Q1 | $576K | Buy |
17,504
+7,578
| +76% | +$388K | ﹤0.01% | 2186 |
|
|
2018
Q4 | $590K | Buy |
9,926
+1,637
| +20% | +$162K | ﹤0.01% | 1990 |
|
|
2018
Q3 | $1.16M | Buy |
8,289
+4,914
| +146% | +$596K | ﹤0.01% | 1870 |
|
|
2018
Q2 | $414K | Sell |
3,375
-1,848
| -35% | -$157K | ﹤0.01% | 2753 |
|
|
2018
Q1 | $467K | Buy |
5,223
+136
| +3% | +$11.5K | ﹤0.01% | 2505 |
|
|
2017
Q4 | $282K | Buy |
5,087
+2,425
| +91% | +$109K | ﹤0.01% | 2760 |
|
|
2017
Q3 | $112K | Buy |
+2,662
| New | +$111K | ﹤0.01% | 2642 |
|
|
2015
Q2 | – | Sell |
-1,641
| Closed | -$780K | – | 2961 |
|
|
2015
Q1 | $780K | Buy |
+1,641
| New | +$779K | ﹤0.01% | 1730 |
|
Other funds holding LRMR
DM
BOCH
ACM
DCM
VCM
DCM
DTC